{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:23:43Z","timestamp":1793381023260,"version":"4.5.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>With the emergence of multidrug-resistant strains,<jats:italic>Acinetobacter baumannii<\/jats:italic>infection is becoming a thorny health problem in hospitals. However, there are no licensed vaccines against<jats:italic>A. baumannii<\/jats:italic>.<jats:italic>Acinetobacter<\/jats:italic>trimeric autotransporter (Ata) is an important known virulence factor located on the outer membrane of bacteria. Herein, we carried out a series of experiments to test the immunogenicity of a short C-terminal extracellular region of Ata (Ata<jats:sub>\u03b1<\/jats:sub>, only containing 39 amino acids) in a murine model. The short peptide Ata<jats:sub>\u03b1<\/jats:sub>was fused with the cholera toxin B subunit (CTB), which has been reported to have immunoadjuvant activity. The fusion protein showed no inflammation and organ damages, and have the ability to elicit both Th1 and Th2 immune responses in mice. The bactericidal activities against<jats:italic>A. baumannii<\/jats:italic>and prophylactic effects of the fusion protein were further evidenced by a significant reduction in the bacterial load in the organs and blood. In addition, the candidate vaccine could provide broad protection against lethal challenges with a variety of<jats:italic>A. baumannii<\/jats:italic>strains. Moreover, when CpG was added on the basis of aluminum adjuvant, the immune response, especially cellular immunity, could be further strengthened. Overall, these results revealed that the Ata<jats:sub>\u03b1<\/jats:sub>is a promising vaccine target against<jats:italic>A. baumannii<\/jats:italic>infection.<\/jats:p>","DOI":"10.3389\/fimmu.2022.884555","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T08:16:19Z","timestamp":1649837779000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["A Short Peptide of Autotransporter Ata Is a Promising Protective Antigen for Vaccination Against Acinetobacter baumannii"],"prefix":"10.3389","volume":"13","author":[{"given":"Peng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318298a541","article-title":"Eighteen Years of Experience With Acinetobacter Baumannii in a Tertiary Care Hospital","volume":"41","author":"Munoz-Price","year":"2013","journal-title":"Crit Care Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/QCO.0000000000000518","article-title":"Managing Acinetobacter Baumannii Infections","volume":"32","author":"Garnacho-Montero","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1086\/500202","article-title":"The Epidemiology and Control of Acinetobacter Baumannii in Health Care Facilities","volume":"42","author":"Fournier","year":"2006","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1754","article-title":"International Study of the Prevalence and Outcomes of Infection in Intensive Care Units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3150965","DOI":"10.1155\/2018\/3150965","article-title":"Determinants of Mortality in Patients With Nosocomial Acinetobacter Baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study","volume":"2018","author":"Yang","year":"2018","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"B6","article-title":"Acinetobacter Baumannii: An Emerging and Important Pathogen","volume":"17","author":"Alsan","year":"2010","journal-title":"J Clin Outcomes Manag"},{"key":"B7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/pathogens10030373","article-title":"Acinetobacter Baumannii Antibiotic Resistance Mechanisms","volume":"10","author":"Kyriakidis","year":"2021","journal-title":"Pathog"},{"key":"B8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/21505594.2018.1558693","article-title":"The Acinetobacter Trimeric Autotransporter Adhesin Ata Controls Key Virulence Traits of Acinetobacter Baumannii","volume":"10","author":"Weidensdorfer","year":"2019","journal-title":"Virulence"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vaccine.2010.10.052","article-title":"Active and Passive Immunization Against Acinetobacter Baumannii Using an Inactivated Whole Cell Vaccine","volume":"29","author":"McConnell","year":"2010","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.12.020","article-title":"A Lethal Pneumonia Model of Acinetobacter Baumannii: An Investigation in Immunocompetent Mice","volume":"25","author":"Zeng","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.017","article-title":"Vaccination With a Live Attenuated Acinetobacter Baumannii Deficient in Thioredoxin Provides Protection Against Systemic Acinetobacter Infection","volume":"35","author":"Ainsworth","year":"2017","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.06.001","article-title":"Outer Membrane Vesicles as an Acellular Vaccine Against Acinetobacter Baumannii","volume":"29","author":"McConnell","year":"2011","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1927412","article-title":"Facing the Challenges of Multidrug-Resistant Acinetobacter Baumannii: Progress and Prospects in the Vaccine Development","volume":"17","author":"Mat Rahim","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00741-10","article-title":"Vaccination With Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-Resistant Acinetobacter Baumannii","volume":"79","author":"McConnell","year":"2011","journal-title":"Infect Immun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029446","article-title":"Active and Passive Immunization Protects Against Lethal, Extreme Drug Resistant-Acinetobacter Baumannii Infection","volume":"7","author":"Luo","year":"2012","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.031","article-title":"OmpW Is a Potential Target for Eliciting Protective Immunity Against Acinetobacter Baumannii Infections","volume":"33","author":"Huang","year":"2015","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00158","article-title":"Immunoprotective Efficacy of Acinetobacter Baumannii Outer Membrane Protein, FilF, Predicted In Silico as a Potential Vaccine Candidate","volume":"7","author":"Singh","year":"2016","journal-title":"Front Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"12411","DOI":"10.1038\/s41598-017-12789-3","article-title":"Immunoprotective Potential of BamA, the Outer Membrane Protein Assembly Factor, Against MDR Acinetobacter Baumannii","volume":"7","author":"Singh","year":"2017","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2011.09.004","article-title":"Protection Against Acinetobacter Baumannii Infection via Its Functional Deprivation of Biofilm Associated Protein (Bap)","volume":"51","author":"Fattahian","year":"2011","journal-title":"Microb Pathog"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e62160","DOI":"10.1371\/journal.pone.0062160","article-title":"Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter Baumannii Genomes","volume":"8","author":"Kenyon","year":"2013","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070329","article-title":"Diversity in the Major Polysaccharide Antigen of Acinetobacter Baumannii Assessed by DNA Sequencing, and Development of a Molecular Serotyping Scheme","volume":"8","author":"Hu","year":"2013","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/JB.06769-11","article-title":"Identification of Ata, a Multifunctional Trimeric Autotransporter of Acinetobacter Baumannii","volume":"194","author":"Bentancor","year":"2012","journal-title":"J Bacteriol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.1c00021","article-title":"The Acinetobacter Baumannii Autotransporter Adhesin Ata Recognizes Host Glycans as High-Affinity Receptors","volume":"7","author":"Tram","year":"2021","journal-title":"ACS Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.06096-11","article-title":"Evaluation of the Trimeric Autotransporter Ata as a Vaccine Candidate Against Acinetobacter Baumannii Infections","volume":"80","author":"Bentancor","year":"2012","journal-title":"Infect Immun"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-021-02343-1","article-title":"A Conserved Region of Acinetobacter Trimeric Autotransporter Adhesion, Ata, Provokes Suppression of Acinetobacter Baumannii Virulence","volume":"203","author":"Hatefi Oskuei","year":"2021","journal-title":"Arch Microbiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00443-16","article-title":"Biosynthesis of Conjugate Vaccines Using an O-Linked Glycosylation System","volume":"7","author":"Pan","year":"2016","journal-title":"mBio"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2494(98)80144-2","article-title":"The Mechanism of Cholera Toxin Adjuvanticity","volume":"148","author":"Lycke","year":"1997","journal-title":"Res Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/toxins7030974","article-title":"Cholera Toxin B: One Subunit With Many Pharmaceutical Applications","volume":"7","author":"Baldauf","year":"2015","journal-title":"Toxins (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines3030579","article-title":"Cholera Toxin Subunit B as Adjuvant\u2013An Accelerator in Protective Immunity and a Break in Autoimmunity","volume":"3","author":"Stratmann","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.9.5716-5725.2001","article-title":"Cholera Toxin B Subunit as a Carrier Molecule Promotes Antigen Presentation and Increases CD40 and CD86 Expression on Antigen-Presenting Cells","volume":"69","author":"George-Chandy","year":"2001","journal-title":"Infect Immun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.9.5654-5665.2005","article-title":"Heteropentameric Cholera Toxin B Subunit Chimeric Molecules Genetically Fused to a Vaccine Antigen Induce Systemic and Mucosal Immune Responses: A Potential New Strategy to Target Recombinant Vaccine Antigens to Mucosal Immune Systems","volume":"73","author":"Harakuni","year":"2005","journal-title":"Infect Immun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.13770","article-title":"Safety and Immunogenicity of a New Glycoengineered Vaccine Against Acinetobacter Baumannii in Mice","volume":"15","author":"Li","year":"2021","journal-title":"Microb Biotechnol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter Baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options","volume":"7","author":"Lee","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2014.12.010","article-title":"A Domain Dictionary of Trimeric Autotransporter Adhesins","volume":"305","author":"Bassler","year":"2015","journal-title":"Int J Med Microbiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2019.03.023","article-title":"Trimeric Autotransporter Adhesins in Acinetobacter Baumannii, Coincidental Evolution at Work","volume":"71","author":"Rahbar","year":"2019","journal-title":"Infect Genet Evol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048830","article-title":"AtaA, a New Member of the Trimeric Autotransporter Adhesins From Acinetobacter Sp. Tol 5 Mediating High Adhesiveness to Various Abiotic Surfaces","volume":"7","author":"Ishikawa","year":"2012","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41541-017-0037-1","article-title":"Design and Production of Conjugate Vaccines Against S. Paratyphi A Using an O-Linked Glycosylation System In Vivo","volume":"3","author":"Sun","year":"2018","journal-title":"NPJ Vaccines"},{"key":"B38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/microorganisms8030436","article-title":"Application of an O-Linked Glycosylation System in Yersinia Enterocolitica Serotype O:9 to Generate a New Candidate Vaccine Against Brucella Abortus","volume":"8","author":"Huang","year":"2020","journal-title":"Microorganisms"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100549","article-title":"Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine Against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host","volume":"8","author":"Peng","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat4615","article-title":"Glycoconjugate Vaccines: Principles and Mechanisms","volume":"10","author":"Rappuoli","year":"2018","journal-title":"Sci Transl Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1819612116","article-title":"On the Mechanisms of Conjugate Vaccines","volume":"116","author":"Rappuoli","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2535","article-title":"A Mechanism for Glycoconjugate Vaccine Activation of the Adaptive Immune System and Its Implications for Vaccine Design","volume":"17","author":"Avci","year":"2011","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"113867","DOI":"10.1016\/j.addr.2021.113867","article-title":"Prophylactic Vaccine Delivery Systems Against Epidemic Infectious Diseases","volume":"176","author":"Pan","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of Nanotechnology for Immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/vaccines9060542","article-title":"Expression of Bordetella Pertussis Antigens Fused to Different Vectors and Their Effectiveness as Vaccines","volume":"9","author":"Xu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/toxins6041397","article-title":"Immunogenicity of a West Nile Virus DIII-Cholera Toxin A2\/B Chimera After Intranasal Delivery","volume":"6","author":"Tinker","year":"2014","journal-title":"Toxins (Basel)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4161\/hv.28371","article-title":"Cholera Toxin B Subunit Acts as a Potent Systemic Adjuvant for HIV-1 DNA Vaccination Intramuscularly in Mice","volume":"10","author":"Hou","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e2002940","DOI":"10.1002\/adma.202002940","article-title":"Biosynthesis of Self-Assembled Proteinaceous Nanoparticles for Vaccination","volume":"32","author":"Pan","year":"2020","journal-title":"Adv Mater"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/8.12.1849","article-title":"Cholera Toxin B Subunit Binding to an Antigen-Presenting Cell Directly Co-Stimulates Cytokine Production From a T Cell Clone","volume":"8","author":"Li","year":"1996","journal-title":"Int Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal Adjuvants and Anti-Infection and Anti-Immunopathology Vaccines Based on Cholera Toxin, Cholera Toxin B Subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunol Lett"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.4.1740-1747.2003","article-title":"Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination With Different Influences on Th1 and Th2 Development","volume":"71","author":"Eriksson","year":"2003","journal-title":"Infect Immun"},{"key":"B52","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/nano12050734","article-title":"Construction of Orthogonal Modular Proteinaceous Nanovaccine Delivery Vectors Based on mSA-Biotin Binding","volume":"12","author":"Shi","year":"2022","journal-title":"Nanomaterials"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.3.1586","article-title":"Transcutaneous Immunization With Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses via Selective Induction of Th1 Immune Responses","volume":"170","author":"Anjuere","year":"2003","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-015-4316-3","article-title":"Protective Immunity Against Naegleria Fowleri Infection on Mice Immunized With the Rnfa1 Protein Using Mucosal Adjuvants","volume":"114","author":"Lee","year":"2015","journal-title":"Parasitol Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.041","article-title":"Therapeutic Efficacy of the Multi-Epitope Vaccine CTB-UE Against Helicobacter Pylori Infection in a Mongolian Gerbil Model and Its microRNA-155-Associated Immuno-Protective Mechanism","volume":"32","author":"Lv","year":"2014","journal-title":"Vaccine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1348-0421.2005.tb03632.x","article-title":"Recombinant Cholera Toxin B Subunit Activates Dendritic Cells and Enhances Antitumor Immunity","volume":"49","author":"Isomura","year":"2005","journal-title":"Microbiol Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200324368","article-title":"Coupling of Antigen to Cholera Toxin for Dendritic Cell Vaccination Promotes the Induction of MHC Class I-Restricted Cytotoxic T Cells and the Rejection of a Cognate Antigen-Expressing Model Tumor","volume":"34","author":"Eriksson","year":"2004","journal-title":"Eur J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2008.02085.x","article-title":"The Adjuvant Effect of CpG Oligodeoxynucleotide Linked to the Non-Toxic B Subunit of Cholera Toxin for Induction of Immunity Against H. Pylori in Mice","volume":"67","author":"Nystrom-Asklin","year":"2008","journal-title":"Scand J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1574-695X.2001.tb00535.x","article-title":"CpG ODN can Re-Direct the Th Bias of Established Th2 Immune Responses in Adult and Young Mice","volume":"32","author":"Weeratna","year":"2001","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.2.953-962.2003","article-title":"A Protective Role of Locally Administered Immunostimulatory CpG Oligodeoxynucleotide in a Mouse Model of Genital Herpes Infection","volume":"77","author":"Harandi","year":"2003","journal-title":"J Virol"},{"key":"B61","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.4.2291","article-title":"Bacterial DNA Containing CpG Motifs Stimulates Lymphocyte-Dependent Protection of Mice Against Lethal Infection With Intracellular Bacteria","volume":"162","author":"Elkins","year":"1999","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1908133","article-title":"CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B(R)) Update","volume":"20","author":"Lee","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"B63","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA Is a Potent Enhancer of Specific Immunity in Mice Immunized With Recombinant Hepatitis B Surface Antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2021.06.012","article-title":"A Vaccine Based on the Receptor-Binding Domain of the Spike Protein Expressed in Glycoengineered Pichia Pastoris Targeting SARS-CoV-2 Stimulates Neutralizing and Protective Antibody Responses","author":"Liu","year":"2021","journal-title":"Eng (Beijing)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.884555\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T17:45:09Z","timestamp":1675273509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.884555\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":64,"alternative-id":["10.3389\/fimmu.2022.884555"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.884555","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"article-number":"884555"}}